Catalent’s recent deal to help produce 100 million doses of Moderna’s COVID-19 vaccine candidate is expected to result in 300 new jobs at the Bloomington facility. This is in addition to the 300 new jobs coming from a similar deal with Johnson & Johnson announced in April.
Hundreds of new job openings have already posted and more will go up soon on the Catalent website, said Denis Johnson, general manager of the Bloomington facility.
“We’re in the process of ramping up hiring, especially for skill positions that require more training,” he said.
The deal with Moderna, a biotechnology company headquartered in Cambridge, Massachusetts, was announced publicly Thursday. According to a press release from Catalent, the Bloomington facility will fill